社債の発行による収入、Transfers To Other Comprehensive Income Related To Assets Held For SaleIFRS、のれん償却額 - 医薬品他1件
- 【期間】
| 年度 | 社債の発行による収入 | Transfers To Other Comprehensive Income Related To Assets Held For SaleIFRS | のれん償却額 - 医薬品 | 売上高 - 健康・農業関連事業 |
|---|
| 2008/03 | - | | - | | - | | - | |
| 2009/03 | - | | - | | - | | - | |
| 2010/03 | - | | - | | - | | - | |
| 2011/03 | - | | - | | - | | - | |
| 2012/03 | - | | - | | - | | - | |
| 2013/03 | - | | - | | 37.7億 | | 2676億 | |
| 2014/03 | - | | - | | 50.5億 | +34% | 3306億 | +23.5% |
| 2015/03 | - | | - | | 54.5億 | +7.8% | 3675億 | +11.2% |
| 2016/03 | - | | - | | 59.8億 | +9.8% | 3639億 | -1% |
| 2017/03 | - | | - | | 55.6億 | -7% | 3237億 | -11.1% |
| 2018/03 | 398億 | | - | | - | | - | |
| 2019/03 | 497億 | +25% | - | | - | | - | |
| 2020/03 | 2826億 | +468.3% | - | | - | | - | |
| 2021/03 | 1587億 | -43.8% | - | | - | | - | |
| 2022/03 | 348億 | -78.1% | - | | - | | - | |
| 2024/03 | 398億 | +14.4% | - | | - | | - | |
